Account

Sign in to access your account and subscription

Patent Licensing and Transactions

  • The April Guidance, which supplements prior guidance issued in February, seeks to remind practitioners of existing rules and to educate them on potential risks associated with artificial intelligence tool use, allowing practitioners to mitigate these risks.

    July 01, 2024James DeCarlo
  • Licensing inventions vis-a-vis the licensing of patents is not a new practice by any means. However, the explosion of innovation in industries such as technology and pharmaceuticals has placed patent licensing at the forefront of economic advancement.

    June 01, 2024Jose L. Linares, Mark M. Makhail, Stephanie Reed Traband and Michele McGuire Vanderstreet
  • This article explores the benefits and risks of AI-driven drug discovery from the legal perspective. Since the law governing IP rights in AI-driven drug discovery is still in its infant state, any future legal development is likely to have significant implications in many areas.

    May 01, 2024Fredrick Tsang, Antonia Sequeira and Carl Morales
  • A statutory predicate to the contractual outcome regarding ownership of patent rights is the requirement of a sufficient contribution by a natural person in the effort that yielded the output. The issues implicated by this requirement are one development among more to come as patent law and policy try to catch up to proliferating AI technology.

    May 01, 2024Jim Soong
  • Federal Circuit Weighs On the Patentability of Claims to Targeted Advertising Federal Circuit Clarifies the Result-Effective Variable Doctrine

    May 01, 2024Jeffrey S. Ginsberg and Kaiying Wang
  • As technology continues to permeate the legal industry, the significance of IP in safeguarding innovations, ensuring fair competition, and fostering a culture of creative legal solutions becomes paramount.

    April 01, 2024Brian Mack, Kevin Keller and Olga V. Mack